Pharmaceutical Enzymes
Pharmaceutical Enzymes – Table of Contents
 | Volume 84 of the series “Drugs and the pharmaceutical sciences” (executive editor: J. Swarbrick) For further information, email to: fip.enzymes@ugent.be |
Bioavailability of pharmaceutical enzymes
- Biopharmaceutical aspects of enzyme absorption
Joseph Demeester - The endothelium monolayer: barrier to enzyme and drug delivery
Felicia Antohe and Mark J. Poznansky
Tailoring of pharmaceutical enzymes
- Enzyme-albumin conjugates: advantages and problems with targeting
,Mark J. Poznansky and Felicia Antohe - Acyl enzymes as prodrugs
Fritz Markwardt - Molecular modeling of pharmaceutically important targets
Gerrit Vriend, Dirk Hendriks and Simon Scharpé
Biochemical and pharmacological properties
- The cysteine proteinases from the latex of Carica papaya L.
Albert Lauwers and Philippe M. Dekeyser - Bromelain
Greet Vanhoof and Walter Cooreman - Hyaluronidase
Joseph Demeester and Koen P. Vercruysse - Pancreatic enzyme replacement
Simon Scharpé, Wim Uyttenbroeck and Nele Samyn - I-asparaginase: an essential antineoplastic drug
Volker Wahn - Macrophage-targeted glucocerebrosidase: a therapeutically effective enzyme replacement product for Gaucher disease
Norman W. Barton and Roscoe O. BradyI - Deoxyribonuclease I
Ingrid Demeester and Stefaan C. De Smedt - Therapeutic protein inhibitors of elastase
David Farley, Bernard Faller and Hanspeter Nick
Standardization and methodology
- Good standardization practices
Albert Lauwers - Assays
Joseph Demeester, Philippe M. Dekeyser, Nele Samyn, Ingrid Verhamme, Willy Sierens and Albert Lauwers